Back to TLA

Search Results - yves+lussier

2 Results

Sort By:

Predictive mRNA Biomarker for Progressive Coccidioidomycosis When Infected

This invention introduces a blood-based diagnostic test to assess coccidioidomycosis progression risk. The test is broken down into three overall steps: 1) blood collection, 2) ex vivo stimulation, and 3) mRNA quantification. This technology identified a predictive a gene set/biomarkers for coccidioidomycosis that was independently validated across...

Published: 5/19/2025 | Inventor(s): John Galgiani, Yves Lussier

Keywords(s):

Category(s): Technology Classifications > Healthcare Portfolios > Infectious Diseases, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Research Tools

Pharmacogenomics of Intergenic SNPs and in Silico Modeling for Precision Therapy

This invention is a method for analyzing a single patient’s DNA and modeling how mutations and variations in intra-cell genomics will be expressed in the body. The information may be used to develop highly personalized therapies without the need for huge experimental data sets. Background: Personalized medicine is the next frontier in therapeutics....

Published: 11/16/2023 | Inventor(s): Yves Lussier, Ikbel Achour, Joanne Berghout, Haiquan Li

Keywords(s):

Category(s): Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Life Sciences > Therapeutics